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INTRODUCTION
Orientia tsutsugamushi causes scrub typhus, which is endemic
in many countries in the Asia-Pacific region, including Korea
(1, 2). This disease is an acute febrile illness characterized by
fever, rash, and eschar. The mechanism of its pathogenesis
has not been studied extensively, but is believed to be simi-
lar to that of other Rickettsia, which includes endothelial da-
mage and subsequent vasculitis (3). 
Doxycycline has been used as the drug of choice for scrub
typhus. However, recent reports of doxycycline-resistant strains
in Thailand have stimulated the research on alternative antibi-
otics for the treatment of this disease (4). Because the inci-
dence of scrub typhus has recently increased markedly, there
is growing concern about the possible occurrence of a resis-
tant strain in Korea. Therefore, it is necessary to test the sus-
ceptibility of Korean isolates of O. tsutsugamushi to doxycy-
cline and other antibiotics (5).
The testing of O. tsutsugamushi antibiotic susceptibility has
not been standardized because it requires viable host cells for
bacterial growth. In a previous study, we reported the char-
acteristics of a monoclonal antibody (MAb), M686-13, that
reacts exclusively with intracellular O. tsutsugamushi, and its
application in an immunofluorescence assay (IFA) to deter-
mine antibiotic susceptibility (6, 7). However, that method
requires the manual count of bacterial particles or computer-
assisted scanning. Therefore, we were interested in finding
an objective and convenient method with which to accurately
quantify O. tsutsugamushi.
Flow cytometry has been used previously for antibiotic-sus-
ceptibility testing of intracellular pathogens (8-13). A pio-
neering work by Kelly et al. described the use of flow cytom-
etry to measure the growth of O. tsutsugamushi in cells treat-
ed with antibiotics (14). Although their method is relatively
rapid and objective, it is not sufficiently sensitive to distin-
guish quantitatively between low levels of infection. More-
over, it may be less sensitive for the detection of diverse local
strains that are antigenically heterogeneous (14). We specu-
lated that low sensitivity resulted from the use of polyclonal
animal serum to stain the bacteria. Therefore, we decided to
improve the efficiency of flow cytometric detection by using
a specific MAb.
In this study, we demonstrate an improved flow-cytomet-
ric approach to the sensitive and quantitative measurement
of the growth of O. tsutsugamushi. We used our method to
determine the doxycycline susceptibility of strains from Korea
and Thailand.
MATERIALS AND METHODS
Cell culture and O. tsutsugamushi
Cells of the human umbilical-vein-derived endothelial cell
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line ECV304 were maintained in M199 medium (Gibco
BRL, Gaithersburg, MD, U.S.A.) supplemented with 10%
(v/v) heated-inactivated fetal bovine serum (Gibco BRL) in
a humidified atmosphere containing 5% CO2 at 37℃. The
Boryong serotype of O. tsutsugamushi (15) was cultivated in
ECV304 cells, as described previously (16). The Thailand
strains (AFSC-4, AFSC-7, TA686, TA678, TA716, TA763,
and TH1817) were kindly provided by Dr. Daniel Strickman,
Naval Medical Research Institute, U.S.A.. The Karp (ATCC
VR-150) and Gilliam (ATCC-VR-312) strains were obtained
from American Type Culture Collection; Kato strain was
donated from Dr. Hiroshi Tanaka, the Institute of Medical
Science, Tokyo University, Japan. Kuroki and Kawasaki strains
were donated from Dr. Akira Tamura, Department of Micro-
biology, Niigata College of Pharmacy, Japan. All bacterial
strains were cultivated in ECV304 cells. When infected ECV-
304 cells showed maximum cytopathic effects, the cells were
disrupted with glass bead (diameter 1.0 mm) and centrifuged
at 300×g for 5 min. The resulting supernatants were imme-
diately used to infect further ECV304 cells. 
Treatment with doxycycline 
ECV304 cells grown in 6-well plates were incubated with
O. tsutsugamushi for 3 hr, allowing time for O. tsutsugamushi to
attach to and enter the host cells. At the end of the initial
incubation period, the inoculums were replaced with fresh
medium containing two-fold dilutions of doxycycline (Sig-
ma, St. Louis, MO, U.S.A.) from 0.2  g/mL to 0.00625  g/
mL, and the cells were then re-incubated in 5% CO2 at 37℃
for three days. Doxycycline was prepared in aliquots of 0.5
mL at an active concentration of 5,000  g/mL in sterile dis-
tilled water. These aliquots were stored frozen at -20℃until
required.
Monoclonal antibodies and selection of antibodies for the
application in flow cytometry
MAb FS15 and FS10 react against a linear epitope on 56-
kDa major outer membrane protein of O. tsutsugamushi (17).
Other MAbs (Rb167, Rb134, M686-8, and Shim107) were
obtained from cell fusion experiments of spleen cells of mice
immunized with live O. tsutsugamushi, as described previously
(6, 18). For its application to flow cytometry, MAb FS15 was
purified on an AffinityPak Protein A Column (Pierce Biotech-
nology Rockford, IL, U.S.A.) and conjugated with fluores-
cein isothiocyanate (FITC) with EZ-label Fluorescein Pro-
tein Labeling Kit (Pierce Biotechnology), according to the
manufacturer’s instruction.
To select a suitable MAb for the application in flow cytom-
etry, we tested the immunoreactivities of MAbs to various
strains of O. tsutsugamushi using IFA. Among the tested MAbs,
we selected the MAb that had broad reactivity to many strains
and stained the bacteria brightly. 
Immunofluorescent antibody staining 
The reactivities of MAbs to various strains of O. tsutsuga-
mushi were examined using IFA. ECV304 cells infected with
each strain were fixed with acetone-methanol (1:1) or acetone
and treated with dilutions of MAbs in phosphate-buffered
saline (PBS) for 1 hr at 37℃. After the cells had been washed
briefly with PBS, they were treated with FITC-conjugated
goat anti-mouse IgG (Jackson ImmunoResearch, West Grove,
PA, U.S.A.) for 1 hr in a moist chamber, and then washed three
times with PBS. To clearly define the O. tsutsugamushi, the
host cells were counter-stained with 0.003% Evans blue in
PBS. After the slides had been washed, they were placed on
mounting medium (Vector Laboratories, Burlingame, CA,
U.S.A.) and examined under a fluorescence microscope (Ni-
kon, Japan) with a confocal laser scanning system (Bio-Rad,
Hercules, CA, U.S.A.). 
Immunogold electron microscopy 
ECV304 cells infected with O. tsutsugamushi were grown
for seven days and were fixed with 0.5% glutaraldehyde, 4%
paraformaldehyde and 3.5% sucrose and postfixed with 1%
osmium tetroxide (OsO4). After dehydration in an ethanol
series, the pellets were embedded in Epon 812. After the
collection of ultrathin sections on Formvar/carbon-coated
nickel grids, the grids were floated on drops of 3% sodium
metaperiodate for 30 min. The immunogold labeling pro-
cedure (19) was done using MAb FS15 and 15 nm gold-
conjugated goat anti-mouse IgG. After immunogold label-
ing, the grids were stained with uranyl acetate and lead cit-
rate, and was viewed with a Hitachi H7100 electron micro-
scope.
Flow cytometry assay and data processing
To quantify O. tsutsugamushi in ECV304 cells, infected cells
were trypsinized, washed with PBS, and centrifuged at 300
×gfor 5 min. The cells were fixed with 70% ethanol for 1 hr
on ice and stored at -20℃ until analyzed. Before their appli-
cation to flow cytometry, fixed cells were washed with PBS
and the resulting cell pellets were resuspended in 500  L of
FITC-conjugated MAb FS15 diluted with PBS, and analyzed
with a flow cytometer (Becton Dickinson, Mansfield, MA,
U.S.A.) equipped with a 15 mW argon laser. Data were col-
lected on 10,000 cells and analysis was performed using LYSIS
II software (Becton Dickinson). To calculate an estimate of
the total mass of bacteria in the cells, the percentage of posi-
tive cells was multiplied by the mean fluorescence intensity
of these cells to obtain the growth index (GI). The MIC was
defined as the concentration of antibiotics at which GI was
reduced by 90% relative to that of control cells that were
infected and incubated in the absence of doxycycline. Flow Cytometric Test of Doxycycline Susceptibility of O. tsutsugamushi  3
RESULTS
Reactivity of MAb selected for the application in flow
cytometry
The tested MAbs could stain O. tsutsugamushi brightly in
IFA (Fig. 1A). Although the MAbs showed similar morpho-
logies of bacteria, their staining patterns differed slightly
according to the target antigens. In addition, the bacterial
particles stained by MAbs (FS10, FS15, and Rb167) direct-
ed against the 56-kDa scrub typhus antigen (Sta56) were
brighter and bigger than those stained by MAbs (Rb134,
M686-8, and Shim107) directed against other antigens. There-
fore, we reasoned that MAbs against Sta56 are suitable as the
primary antibodies for the use in flow cytometry. Among
them, we selected FS15 because the target epitope of this
MAb has been well characterized in a previous study (17).
Furthermore, the antigenic epitope is located at the surface
of the cell envelope as shown by immunogold electron mic-
roscopy (Fig. 2A). As Sta56 has strain-specific and group-spe-
cific epitopes, we tested the reactivity of FS15 to other strains
of O. tsutsugamushi. As shown in Fig. 2B. MAb FS15 stained
most of the O. tsutsugamushi strains (Boryong, Karp, Kato,
AFSC-4, AFSC-7, TA686, TA763, TH1817, Kawasaki and
Kuroki) originating from several Asian nations in IFA, except
Gilliam, TA678, and TA716 strains.
Growth of O. tsutsugamushi measured by flow cytometry
To test the applicability of FITC-conjugated FS15 to the
quantification of the total mass of O. tsutsugamushi by flow
cytometry, we first used this MAb to determine the growth
of O. tsutsugamushi. We infected the ECV304 cells with high
(84.6% cells are infected 3-day postinfection) and low num-
bers (12.2% cells are infected 3-day postinfection) of O. tsut-
sugamushi and measured bacterial growth for seven days using
flow cytometry. Under both conditions, flow cytometry de-
monstrated the significant growth of O. tsutsugamushi, which
appeared at as early as one day after infection and progressed
further until seven days after infection. This is evident in the
right-hand shift of the entire peak of cells infected with high
numbers of bacteria (Fig. 3A) and the appearance of a new
peak in cells infected with low numbers of bacteria (Fig. 3B).
Because three days incubation was sufficient to demonstrate
bacterial growth by flow cytometric parameters, we selected
this time point for subsequent work. 
Determination of antibiotic susceptibility of O. tsutsuga-
mushi by flow cytometry 
To test the applicability of flow cytometry to the determi-
nation of the doxycycline susceptibility of the Boryong strain,
which is the most prevalent strain in Korea (15), infected
ECV304 cells were treated with various concentrations of
doxycycline for three days, and then bacterial growth was
measured by flow cytometry. As shown in Fig. 4A, the fluo-
rescence peak shifted to left as the concentration of doxycy-
cline increased, as indicated by the percentage of positive cells
in each histogram. The percentage of positive cells infected
with Boryong after treatment with 0.1  g/mL doxycycline
Fig. 1. IFA staining of MAbs Boryong strains of O. tsutsugamushi.
MAbs directed against a Sta56 show brighter and bigger bacterial
particles than those seen by MAbs against other antigens (×80). 
Fig. 2. Reactivity of MAb FS15 selected for the application in flow
cytometry. (A) Immunogold staining of O. tsutsugamushi with MAb
FS15 shows that epitope of FS15 was located at the surface of
the cell envelope (×25,000). (B) MAb FS15 reacts positively against
10 strains out of 13 strains from various nations (×20). 
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was 1.7% (Fig. 4A). In the presence of 0.1 or 0.2  g/mL doxy-
cycline, no bacterial growth was observed and the percentage
of positive cells decreased to that of the control (uninfected)
cells. Thus, the MIC was determined to be 0.1  g/mL. 
Next, we used our method to determine the doxycycline
susceptibility of O. tsutsugamushi strain AFSC-4, which is
reported to be resistant to doxycycline (5). The percentage
of positive cells infected with AFSC-4 after treatment with
0.1  g/mL doxycycline was 3.1% and the MIC was 0.1  g/
mL (Fig. 4B). When we compared the doxycycline suscepti-
bility of the Boryong and AFSC-4 strains, both strains showed
similar patterns of inhibition by doxycycline. The percentages
of GI of Boryong and AFSC-4 strains after the treatment with
0.1  g/mL doxycycline were 1.29% and 4.11% respective-
ly, where 100% represented the percentage of infected cells
without doxycycline treatment (Fig. 4C). 
DISCUSSION
In this study, we have demonstrated that flow cytometry
using specific MAb can be used to reliably quantify the total
Fig. 4. Comparison of susceptibility of the Boryong and AFSC-4
strains to doxycycline. Flow-cytometric histograms of ECV304 cells
infected with the Boryong (A) or AFSC-4 strain (B) in the presence
of increasing concentrations of doxycycline (0-0.2  g/mL) were
measured after three day incubation. Control represents the result
from the uninfected cells. The histograms are representative of
three independent experiments. The GI of each strain was calcu-
lated and plotted as a percentage of fluorescence intensity (C),
where 100% represents the percentage of infected cells without
doxycycline treatment. Bars represent means±SD (n=3). 
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Fig. 3. Flow cytometric histograms of ECV304 cells infected with a high dose (A) or low dose (B) of Boryong strain at the indicated times.
Control represented the result from uninfected cells. The percentages of positive cells for O. tsutsugamushi are marked in the histogram.
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Bmass of O. tsutsugamushi. Traditional methods of quantifying
other Rickettsia, such as the determination of the reduction
in plaque formation or the dye-uptake assay (20), are seldom
used for Orientia because it requires a long incubation time to
form plaques (21). The most frequently used method involves
counting Giemsa-stained bacteria after 3-4 days of antibiotic
treatment (5). Whereas this method requires few special rea-
gents, it is time-consuming and complicated owing to diffi-
culties in quantifying the bacterial particles microscopically
because of their tendency to form aggregates in cells (22, 23).
With our method using flow cytometry, a right-hand shift
of the entire peak or the appearance of a new peak was observed
as O. tsutsugamushi divided. These results were in contrast to
a previous trial using flow cytometry, in which only a slight
right-hand shift occurred in the fluorescence peak of infect-
ed cells and seemed to be essentially qualitative rather than
quantitative (14).
The MAb is the most important parameter in the sensitive
detection of O. tsutsugamushi by flow cytometry. For the detec-
tion of bacteria in cells by flow cytometry, a primary antibody
must have several properties: 1) it must be species-specific
to detect various strains of O. tsutsugamushi, which is partic-
ularly important when we consider the antigenic heterogene-
ity of this bacterium; 2) target antigen should be expressed
in large amounts, so that the antibody stains bacteria bright-
ly; and 3) it must be available in large amounts so that the
same reagent can be used in future applications.
We used a mouse MAb that is reactive against Sta56 of O.
tsutsugamushi. This protein is abundantly expressed at the
surface of the bacterium and is believed to be important in
its pathogenesis (1). It has strain-specific and species-specif-
ic epitopes and is a major target of strain-specific immunity
to O. tsutsugamushi. MAb FS15 was well characterized in our
previous study as being reactive against amino acid residues
187-214 of Sta56. MAb FS15 was also reactive strongly on
IFA against various strains of O. tsutsugamushi, including the
most prevalent strain in Korea (15). Therefore, it can be used
to test the antibiotic susceptibility of most strains. The mor-
phologies of the bacteria stained with various MAbs on IFA
differed according to the target antigen of each MAb. Interest-
ingly, MAbs directed against Sta56 showed bigger and bri-
ghter bacterial particles than those detected by MAbs against
other antigens of O. tsutsugamushi (Fig. 1). This is one of the
desirable properties of an antibody to be used with flow cyto-
metry. Our explanation for this finding is that Sta56 is an
abundantly expressed protein at the cell surface of this bac-
terium. Of the MAbs directed against Sta56, we chose FS15
because it shows minimal nonspecific staining of host cells
(data not shown).
The MIC of doxycycline was 0.1  g/mL for both the Bory-
ong and AFSC-4 strains when we measured bacterial growth
after treatment with doxycycline for three days. This result
is consistent with that of our previous study, in which we
determined the antibiotic susceptibility of both strains using
IFA (7). However, strain AFSC-4 is reported to be doxycy-
cline-resistant and its MIC was reported to be 0.25  g/mL
(5). Although our approach produced an unexpected result,
we would like to point that our method using flow cytome-
ter is more objective than the microscopic count of Giemsa-
stained bacterial particles used by authors of report for AFSC-
4 strain (5). Although clinical experiences support the occur-
rence of infections by strains that are poorly responsive to
doxycycline in northern Thailand, there are few reports about
the biology of resistant strains and their mechanism for resis-
tance. Therefore, further studies are required to clarify the
mechanisms of doxycycline resistance of O. tsutsugamushi and
the possible emergence of doxycycline-resistant in Korea.
In summary, we have improved the flow cytometric tech-
nique for the quantification of O. tsutsugamushi growth using
specific MAb directed against Sta56. Our approach is sensi-
tive in measuring the growing bacteria inside the cells. With
this method, we measured the doxycycline susceptibility of
the Boryong and AFSC-4 strains. 
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